Submit Deal

Ashleigh Koss

Communications Director at GILEAD SCIENCES

Manager

Deal Bio

Total Deals8

Valued Deals7

Total Value£13,152M

Avg. Deal Size£1,879M

Market Context

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

Expertise

Key Relationships (8)

Sort

United States

Biotechnology

PublicMajorityAcquisition

target

SYNTHORX

bidder

Sanofi

£1,902m

50 dealmakers

United States

Pharmaceuticals

MajorityAcquisitionPublicTender OfferCross Border

target

Principia Biopharma

bidder

Sanofi

£2,750m

35 dealmakers

Netherlands

Biotechnology

Cross BorderTender OfferPublicMajorityAcquisitionPrivate Equity

target

Kiadis Pharma

bidder

Sanofi

£276m

37 dealmakers

United Kingdom

Biotechnology

AcquisitionMajorityCross BorderPrivate

target

KYMAB

bidder

Sanofi

£811m

68 dealmakers

Italy

Pharmaceuticals

Cross BorderAcquisitionMajorityPrivate

target

Sanofi (pharmaceutical Product Portfolio)

bidder

FIDIA

value n/a

18 dealmakers

United States

Pharmaceuticals

MajorityCross BorderAcquisitionTender OfferPublicPrivate Equity

target

Translate Bio

bidder

Sanofi

£2,302m

52 dealmakers

South Korea

Biotechnology

AcquisitionMajorityPrivateDomestic

target

Samsung Bioepis

bidder

Samsung Biologics

£1,705m

9 dealmakers

United States

Pharmaceuticals

AcquisitionDomesticMajorityPublic

target

Cymabay Therapeutics

bidder

Gilead Sciences

£3,404m

30 dealmakers

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy